Peter C. Adamson

Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study

Yaël P. Mossé, Megan S. Lim, Stephan D. Voss et al. · The Lancet Oncology · 2013 · 701 citations · Full text

Medicine, Oncology, Pediatrics +11

Ethosuximide, Valproic Acid, and Lamotrigine in Childhood Absence Epilepsy

Tracy A. Glauser, Avital Cnaan, Shlomo Shinnar et al. · New England Journal of Medicine · 2010 · 638 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Declining childhood and adolescent cancer mortality

Malcolm A. Smith, Sean F. Altekruse, Peter C. Adamson et al. · Cancer · 2014 · 553 citations · Full text

Medicine, Oncology, Pediatrics +17

Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children’s Oncology Group Study

Yaël P. Mossé, Stephan D. Voss, Megan S. Lim et al. · Journal of Clinical Oncology · 2017 · 403 citations · Full text

Medicine, Oncology, Pharmacology +15

Pharmacokinetics and Safety of Intravenous Voriconazole in Children after Single- or Multiple-Dose Administration

Thomas J. Walsh, Mats O. Karlsson, Timothy Driscoll et al. · Antimicrobial Agents and Chemotherapy · 2004 · 335 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17